×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| VENUS REMEDIES LTD. | 1788.9 | 196 | 1768.6 | 14.66 | 413.0 | 14.8 |
| SMS Lifesciences India Ltd | 846.58 | 48.53 | 846.01 | 18.08 | 356 | 16.9 |
| ZENOTECH LABORATORIES LTD. | 116.14 | 16.93 | 102.22 | 0.28 | 356 | 91.8 |
Venus Remedies Ltd., with Security Code 526953, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 154.9 | 124.7 | 109.4 | 148.5 | 98.6 | 170.1 | 131.2 | 175.1 | 105.8 | 167.0 |
| Expenses | 136.7 | 109.6 | 102.4 | 127.5 | 85.2 | 157.1 | 118.2 | 153.9 | 91.6 | 156.8 |
| Operating Profit | 18.3 | 15.2 | 7.1 | 21.0 | 13.5 | 13.1 | 13.0 | 21.3 | 14.3 | 10.3 |
| OPM % | 11.78% | 12.16% | 6.47% | 14.16% | 13.66% | 7.71% | 9.91% | 12.15% | 13.49% | 6.15% |
| Other Income | 1.4 | 1.8 | 3.8 | 3.2 | 2.1 | 2.9 | 2.4 | 3.9 | 1.6 | 10.7 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 7.6 | 8.8 | 7.0 | 8.1 | 7.3 | 6.2 | 6.3 | 5.7 | 5.8 | 6.2 |
| Profit before tax | 12.1 | 8.2 | 3.9 | 16.2 | 8.2 | 9.9 | 9.1 | 19.5 | 10.1 | 14.8 |
| Tax % | 8.3% | 5.4% | 32.4% | 53.5% | 47.1% | 44.7% | 10.2% | 35.7% | 55.9% | 37.5% |
| Net Profit | 11.1 | 7.7 | 2.6 | 7.5 | 4.3 | 5.5 | 8.2 | 12.5 | 4.5 | 9.3 |
| EPS in Rs | 8.3 | 5.78 | 1.95 | 5.64 | 3.25 | 4.07 | 6.13 | 9.36 | 3.33 | 6.92 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139.9 | 116.9 | 155.6 | 95.2 | 167.7 | 143.4 | 195.2 | 108.6 | 167.5 | 176.9 |
| Expenses | 126.9 | 108.8 | 131.0 | 84.8 | 149.9 | 131.4 | 175.7 | 97.4 | 162.5 | 158.5 |
| Operating Profit | 13.0 | 8.1 | 24.6 | 10.4 | 17.8 | 12.0 | 19.5 | 11.3 | 4.9 | 18.4 |
| OPM % | 9.3% | 6.9% | 15.8% | 10.9% | 10.6% | 8.4% | 10% | 10.4% | 2.9% | 10.4% |
| Other Income | 1.8 | 3.8 | 3.4 | 2.3 | 3.1 | 2.4 | 3.9 | 1.6 | 10.6 | 11.9 |
| Interest | 0.0 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 9.0 | 7.2 | 8.3 | 7.6 | 6.4 | 6.5 | 5.9 | 6.0 | 6.4 | 5.4 |
| Profit before tax | 5.8 | 4.5 | 19.7 | 5.1 | 14.3 | 7.8 | 17.5 | 6.8 | 9.1 | 15.0 |
| Tax % | 7.6% | 27.5% | 43.9% | 76.6% | 30.7% | 12% | 39.9% | 82.2% | 61.3% | 21.2% |
| Net Profit | 5.3 | 3.3 | 11.1 | 1.2 | 9.9 | 6.9 | 10.5 | 1.2 | 3.5 | 19.6 |
| EPS in Rs | 3 | 2 | 8 | 0 | 7 | 5 | 7 | 0 | 2 | 14 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 14% |
| 3 Years: | 4% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 30% |
| 3 Years: | -1% |
| TTM: | 68% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 64% |
| 3 Years: | 5% |
| 1 Year: | -13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 13% |
| 3 Years: | 3% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 28% |
| 3 Years: | -10% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 64% |
| 3 Years: | 5% |
| 1 Year: | -13% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|